Explore
13D/13G Activist Filings
119,139 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Dec 10, 2025 | NWAX.U | New America Acquisition I Corp. | Harraden Circle Investments, LLC | 13G | 6.6% | 2.5M |
| Dec 10, 2025 | SSUP | SUPERIOR INDUSTRIES INTERNATIONAL INC | SUP Parent Holdings, LLC | 13D/A | 0.0% | 0 |
| Dec 10, 2025 | N/A | Liberty Media Corp | John C. Malone | 13D/A | 97.3% | 2.3M |
| Dec 10, 2025 | UWMC | UWM Holdings Corporation | Mat Ishbia | 13D/A | 83.7% | 1.3B |
| Dec 10, 2025 | CFBK | CF BANKSHARES INC. | Castle Creek Capital Partners VII, LP | 13D/A | 6.1% | 388K |
| Dec 10, 2025 | NCPL | Netcapital Inc. | Strategic EP, LLC | 13D/A | 0.0% | 0 |
| Dec 10, 2025 | FULC | FULCRUM THERAPEUTICS, INC. | RA Capital Management, L.P. | 13G/A | 11.2% | 6.1M |
| Dec 10, 2025 | N/A | Artec Global Media, Inc. | Typenex Co-Investment, LLC | 13G/A | 9.9% | 69.9M |
| Dec 10, 2025 | HDSN | HUDSON TECHNOLOGIES INC /NY | Hartree Partners, LP | 13D | 8.7% | 3.8M |
| Dec 10, 2025 | ATXS | Astria Therapeutics, Inc. | Glazer Capital, LLC | 13G | 5.5% | 3.2M |
| Dec 10, 2025 | BLTE | Belite Bio, Inc | Darwin Global Management, Ltd. | 13G | 7.0% | 2.6M |
| Dec 10, 2025 | CMND | Clearmind Medicine Inc. | L.I.A. Pure Capital Ltd. | 13G/A | 10.0% | 6.0M |
| Dec 10, 2025 | CMND | Clearmind Medicine Inc. | Capitalink Ltd. | 13G/A | 10.0% | 6.0M |
| Dec 10, 2025 | PGRE | Paramount Group, Inc. | Saray Value Fund SPC | 13D/A | 5.4% | 12.0M |
| Dec 10, 2025 | NFLT | ETFis Series Trust I | STRATEGIC PLANNING GROUP, LLC | 13G/A | 0.0% | 6K |
| Dec 10, 2025 | ENVB | ENVERIC BIOSCIENCES, INC. | Braeden Lichti | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | ENVB | ENVERIC BIOSCIENCES, INC. | Northstrive Fund II LP | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | MMYT | MakeMyTrip Ltd | GIC Private Ltd | 13G/A | 10.0% | 9.0M |
| Dec 10, 2025 | NCZ | Virtus Convertible & Income Fund II | Advisors Asset Management, Inc. | 13G | 5.3% | 1.0M |
| Dec 10, 2025 | COOT | Australian Oilseeds Holdings Ltd | Arena Investors LP | 13G | 6.3% | 1.8M |
| Dec 10, 2025 | SCIO | FIRST TRUST EXCHANGE-TRADED FUND IV | STRATEGIC PLANNING GROUP, LLC | 13G | 25.3% | 734K |
| Dec 10, 2025 | CXE | MFS HIGH INCOME MUNICIPAL TRUST | Saba Capital Management, L.P. | 13D/A | 5.0% | 1.6M |
| Dec 10, 2025 | N/A | Tiziana Life Sciences Ltd | Chernett Jorey | 13G/A | 5.4% | 6.5M |
| Dec 10, 2025 | AUNA | AUNA S.A. | Fiera Capital (UK) Ltd | 13G | 4.8% | 1.4M |
| Dec 10, 2025 | CCRN | Cross Country Healthcare, Inc. | Magnetar Financial LLC | 13D/A | 5.0% | 1.6M |
| Dec 10, 2025 | CGCT | CARTESIAN GROWTH CORPORATION III | Picton Mahoney Asset Management | 13G | 7.3% | 2.0M |
| Dec 10, 2025 | CGCTU | CARTESIAN GROWTH CORPORATION III | Picton Mahoney Asset Management | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | HSIC | HENRY SCHEIN INC | KKR Hawaii Holdings L.P. | 13D/A | 13.0% | 15.3M |
| Dec 10, 2025 | OVID | Ovid Therapeutics Inc. | Takeda Pharmaceutical Company Limited | 13G/A | 12.3% | 8.8M |
| Dec 10, 2025 | AIFF | Firefly Neuroscience, Inc. | WPC Management Services Inc. | 13D/A | 7.0% | 939K |
| Dec 10, 2025 | HSON | Star Equity Holdings, Inc. | JEFFREY E. EBERWEIN | 13D/A | 27.1% | 1.0M |
| Dec 10, 2025 | MERC | MERCER INTERNATIONAL INC. | Peter R. Kellogg | 13D/A | 36.5% | 24.5M |
| Dec 9, 2025 | MTA | Metalla Royalty & Streaming Ltd. | Tether Holdings, S.A. de C.V. | 13D/A | 6.6% | 6.1M |
| Dec 9, 2025 | N/A | Pacific Coast Oil Trust | SHIPYARD CAPITAL LP | 13D | 8.3% | 3.2M |
| Dec 9, 2025 | ADVM | Adverum Biotechnologies, Inc. | BML Investment Partners, L.P. | 13D/A | 0.0% | 0 |
| Dec 9, 2025 | SBXE.U | SilverBox Corp V | Tenor Capital Management Company, L.P. | 13G | 5.9% | 1.6M |
| Dec 9, 2025 | NPWR | NET Power Inc. | 8 RIVERS CAPITAL, LLC | 13D/A | 22.3% | 23.3M |
| Dec 9, 2025 | CXM | Sprinklr, Inc. | H&F Corporate Investors IX, Ltd. | 13D/A | 33.1% | 66.5M |
| Dec 9, 2025 | LNAI | Lunai Bioworks Inc. | William Anderson Wittekind | 13D/A | 6.8% | 1.8M |
| Dec 9, 2025 | ADVM | ADVERUM BIOTECHNOLOGIES, INC. | Frazier Life Sciences Public Fund, L.P. | 13G/A | 0.0% | 0 |
| Dec 9, 2025 | MGM | MGM Resorts International | IAC Inc. | 13D/A | 24.1% | 65.8M |
| Dec 9, 2025 | MCS | MARCUS CORP | GAMCO INVESTORS, INC. ET AL | 13D | 0.0% | 0 |
| Dec 9, 2025 | NEO | NeoGenomics, Inc. | Millennium Management LLC | 13G | 5.0% | 6.5M |
| Dec 9, 2025 | VTVT | VTV THERAPEUTICS INC. | Samsara BioCapital, L.P. | 13D/A | 6.2% | 246K |
| Dec 9, 2025 | IAS | INTEGRAL AD SCIENCE HOLDING CORP. | Glazer Capital, LLC | 13G | 6.3% | 10.6M |
| Dec 9, 2025 | BELFA | BEL FUSE INC /NJ | GAMCO INVESTORS, INC. ET AL | 13D/A | 0.0% | 0 |
| Dec 9, 2025 | N/A | TPG Twin Brook Capital Income Fund | STRS OHIO | 13G/A | 4.5% | 7.0M |
| Dec 9, 2025 | AMS | AMERICAN SHARED HOSPITAL SERVICES | Stachowiak Raymond C | 13D/A | 23.7% | 1.6M |
| Dec 9, 2025 | GLQ | Clough Global Equity Fund | Saba Capital Management, L.P. | 13D | 5.1% | 949K |
| Dec 9, 2025 | INCR | InterCure Ltd. | Alexander Rabinovich | 13D | 29.4% | 16.8M |